Last Updated : June 4, 2015
Details
FilesGeneric Name:
Evolocumab
Project Status:
Complete
Therapeutic Area:
Primary hyperlipidemia; mixed dyslipidemia
Manufacturer:
Amgen Canada Inc.
Call for patient/clinician input open:
Brand Name:
Repatha
Project Line:
Reimbursement Review
Project Number:
SR0441-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Submission Type:
Initial
Indications:
Primary hyperlipidemia and mixed dyslipidemia
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : June 4, 2015